Efficacy and safety of cannabidiol followed by an open label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicentre, randomised, placebo-controlled study

INTRODUCTION: Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are chronic, systemic, inflammatory diseases, primarily in the musculoskeletal system. Pain and fatigue are key symptoms of RA and AS. Treatment presents a clinical challenge for several reasons, including the progressive nature...

Descripción completa

Detalles Bibliográficos
Autores principales: Hendricks, Oliver, Andersen, Tonny Elmose, Christiansen, Afshin Ashouri, Primdahl, Jette, Hauge, Ellen Margrethe, Ellingsen, Torkell, Horsted, Tina Ingrid, Bachmann, Anja Godske, Loft, Anne Gitte, Bojesen, Anders Bo, Østergaard, Mikkel, Lund Hetland, Merete, Krogh, Niels Steen, Roessler, Kirsten Kaya, Petersen, Kim Hørslev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561449/
https://www.ncbi.nlm.nih.gov/pubmed/31167870
http://dx.doi.org/10.1136/bmjopen-2018-028197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561449/
https://www.ncbi.nlm.nih.gov/pubmed/31167870
http://dx.doi.org/10.1136/bmjopen-2018-028197

Ejemplares similares